Alkeran (Melphalan Injection) and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Alkeran (Melphalan Injection) and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: melphalan
Brand name: Alkeran, Alkeran IV, Evomela
Synonyms: Alkeran (Injection), ALKERAN
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Alkeran (Melphalan Injection)-Insulin degludec
- Alkeran (Melphalan Injection)-Insulin Degludec (U-100) Prefilled Pens
- Alkeran (Melphalan Injection)-Insulin Degludec (U-100) Vials
- Alkeran (Melphalan Injection)-Insulin Degludec (U-200) Prefilled Pens
- Alkeran (Melphalan Injection)-Insulin degludec and liraglutide
- Alkeran (Melphalan Injection)-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Alkeran (Melphalan Tablets)
- Insulin aspart, recombinant Subcutaneous-Alkeran IV
- Insulin aspart, recombinant Subcutaneous-Alkeran Tablets
- Insulin aspart, recombinant Subcutaneous-All Day Allergy
- Insulin aspart, recombinant Subcutaneous-All Day Allergy-D
- Insulin aspart, recombinant Subcutaneous-All Day Pain Relief